Avadel Jumps On $2.1 Billion Takeover Deal. But Buyer, Alkermes, Dives
investors.com/news/technology/avadel-pharmaceuticals-alkermes-buyout-sleep-disorders
Shares of Alkermes and Avadel Pharmaceuticals diverged Wednesday after the former agreed to buy the latter for up to $2.1 billion.
The post Avadel Jumps On $2.1 Billion Takeover Deal. But Buyer, Alkermes, Dives. appeared first on Investor's Business Daily.
This story appeared on investors.com, 2025-10-22 13:33:38.